Avantive Solutions Appoints Thomas Callison as Chief Compliance Officer
We are happy to announce that Thomas Callison has joined our Avantive Solutions team as our new Chief Compliance Officer.
In the role of CCO, Mr. Callison will lead Avantive’s global corporate compliance, quality assurance, and privacy teams. He’ll be responsible for managing the day-to-day operations of the corporate compliance and quality programs, creating a culture of quality and accountability among employees to meet customer expectations, and serve as the main point of contact for issue escalation across Avantive’s products and services.
“Thomas is an experienced business leader with a long track record of developing global quality systems and compliance frameworks in the ever-changing compliance landscape,” said Frank Pettinato, CEO of Avantive Solutions.
“We’re proud to provide a high-level of regulatory processes and compliance procedures, as it’s a crucial part of maintaining our clients’ trust. I look forward to working with Thomas to ensure our adherence as we continue to grow our client roster and expand to new locations.”
Mr. Callison previously worked at Clinical ink, where he led the quality and compliance team to develop solutions for clinical trial eCOA/ePRO, decentralizing clinical data, and quality management. Before that, he worked in the pharmaceutical and medical device industry focused on quality, regulatory adherence, privacy, and ethics.
He is an active member of ASQ and is a Certified Quality Auditor (CQA) and Certified Quality Manager of Organizational Excellence (CQM/OE). He earned his bachelor’s degree from the University of Phoenix and graduated from The Pennsylvania State University with an MPS in Forensics.
For additional info, please click here to download the full press release and follow us on LinkedIn to see more company news and announcements.